Submitted by Anonymous (not verified) on 29 April 2025 - 10:28
Human medicines European public assessment report (EPAR): Xenleta, lefamulin, Date of authorisation: 27/07/2020, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Xenleta, lefamulin, Date of authorisation: 27/07/2020, Revision: 2, Status: Authorised